Search

Denise G Alfonso

Examiner (ID: 9637)

Most Active Art Unit
2662
Art Unit(s)
2662, 2663
Total Applications
95
Issued Applications
36
Pending Applications
47
Abandoned Applications
12

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16686770 [patent_doc_number] => 20210069245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => MIRNA MODULATION OF T CELL SIGNALING AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/960529 [patent_app_country] => US [patent_app_date] => 2019-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960529 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/960529
MIRNA MODULATION OF T CELL SIGNALING AND USES THEREOF Jan 6, 2019 Pending
Array ( [id] => 16728979 [patent_doc_number] => 20210096126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => DIGITALIZED HUMAN ORGANOIDS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/956230 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956230 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/956230
DIGITALIZED HUMAN ORGANOIDS AND METHODS OF USING SAME Dec 20, 2018 Pending
Array ( [id] => 16720390 [patent_doc_number] => 20210087537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/954349 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954349 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/954349
ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF Dec 20, 2018 Pending
Array ( [id] => 18436421 [patent_doc_number] => 20230183715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => SHUTTLE PLASMID REPLICABLE IN CLOSTRIDIUM AND E. COLI AND RECOMBINANT MICROORGANISM PREPARED THEREWITH AND HAVING ENHANCED PENTOSE METABOLISM AND FERMENTATION PERFORMANCE [patent_app_type] => utility [patent_app_number] => 16/767931 [patent_app_country] => US [patent_app_date] => 2018-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9990 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767931 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/767931
SHUTTLE PLASMID REPLICABLE IN CLOSTRIDIUM AND E. COLI AND RECOMBINANT MICROORGANISM PREPARED THEREWITH AND HAVING ENHANCED PENTOSE METABOLISM AND FERMENTATION PERFORMANCE Nov 27, 2018 Pending
Array ( [id] => 16343951 [patent_doc_number] => 20200308601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => EUKARYOTIC CELL LINE [patent_app_type] => utility [patent_app_number] => 16/759632 [patent_app_country] => US [patent_app_date] => 2018-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759632 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/759632
Eukaryotic cell line Oct 24, 2018 Issued
Array ( [id] => 16221273 [patent_doc_number] => 20200246389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => METHODS FOR OBTAINING CARDIOMYOGENIC PRECURSOR CELLS [patent_app_type] => utility [patent_app_number] => 16/649522 [patent_app_country] => US [patent_app_date] => 2018-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649522 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/649522
METHODS FOR OBTAINING CARDIOMYOGENIC PRECURSOR CELLS Sep 20, 2018 Pending
Array ( [id] => 18683948 [patent_doc_number] => 11779658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => Expression vectors comprising engineered genes [patent_app_type] => utility [patent_app_number] => 16/622800 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15586 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622800 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622800
Expression vectors comprising engineered genes Jun 14, 2018 Issued
Array ( [id] => 15832501 [patent_doc_number] => 20200131532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => GENE THERAPY FOR OCULAR DISORDERS [patent_app_type] => utility [patent_app_number] => 16/607834 [patent_app_country] => US [patent_app_date] => 2018-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607834 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/607834
Gene therapy for ocular disorders Apr 23, 2018 Issued
Array ( [id] => 19043784 [patent_doc_number] => 11932870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => Compositions and methods for immune cell modulation in adoptive immunotherapies [patent_app_type] => utility [patent_app_number] => 16/466265 [patent_app_country] => US [patent_app_date] => 2017-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28849 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/466265
Compositions and methods for immune cell modulation in adoptive immunotherapies Dec 3, 2017 Issued
Array ( [id] => 14375627 [patent_doc_number] => 20190161726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => DIFFERENTIATED CELL PRODUCTION METHOD AND CULTURE BAG USED THEREFOR [patent_app_type] => utility [patent_app_number] => 16/321265 [patent_app_country] => US [patent_app_date] => 2017-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4265 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321265
DIFFERENTIATED CELL PRODUCTION METHOD AND CULTURE BAG USED THEREFOR Jul 27, 2017 Pending
Array ( [id] => 14069525 [patent_doc_number] => 20190083650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => TKI PERMEABILITY ENHANCERS [patent_app_type] => utility [patent_app_number] => 15/527685 [patent_app_country] => US [patent_app_date] => 2015-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19796 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527685 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/527685
TKI permeability enhancers Nov 16, 2015 Issued
Menu